secwatch.observer — SEC 8-K summary
======================================

Issuer:     Opus Genetics, Inc. (IRD)
CIK:        0001228627
Form:       8-K
Filed at:   2025-11-06T23:59:59+00:00
Accession:  0001140361-25-040796
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Opus Genetics raises ~$23M in registered direct offering with Perceptive, Nantahala, Balyasny
--------------------------------------------------------------------------------

- Purchase agreement with affiliates of Perceptive, Nantahala, and Balyasny for 3.83M shares and 7.18M pre-funded warrants at $2.09/$2.0899.
- Gross proceeds ~$23M; net proceeds to advance LCA5 and BEST-1 gene therapy programs and for working capital.
- Pre-funded warrants exercisable at $0.0001/share, subject to 4.99%/9.99% beneficial ownership limitation.
- Closing expected November 7, 2025; no placement agent or underwriting discounts.
- Offering registered on Form S-3; customary closing conditions remain.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1228627/000114036125040796/0001140361-25-040796-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1228627/000114036125040796/ny20058362x2_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-25-040796

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer